Drug discovery - Wikipedia, the free encyclopedia
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and/or designed. In the past most drugs have been discovered ...
David Zarling - Wikipedia, the free encyclopedia
CPC drug candidates showed significant pre-clinical efficacy in regression of prostate cancer and prevention of metastasis. Before starting Colby Pharmaceutical Company, Dr. Zarling ...
Drug Candidate For Treating Spinal Muscular Atrophy Identified
A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy, a currently incurable disease that is the leading genetic cause of ...
Human Genome Sciences says it filed application for hepatitis C drug ...
Human Genome Sciences says it filed application for hepatitis C drug candidate Zalbin ... Inc. said Wednesday it has filed for marketing approval of its hepatitis C drug Zalbin.
Hemispherx Biopharma, Inc. -- Research and Development: Drug ...
Ampligen® Nucleic acid compounds represent a potential new class of pharmaceutical products that are designed to act at the molecular level for treatment of human diseases.
Immuneregen
Overview. ImmuneRegen’s current focus is to develop drug candidates for regenerating or strengthening the human immune system, in part, through stimulation of human adult stem ...
Anti-HIV Candidates in the Pipeline - The Body
In the past year or so, the HIV drug pipeline seemed to slow to a trickle, with only one new approval, tenofovir (Viread). But the future is beginning to ...
Keryx Biopharmaceuticals cancer drug candidate gets faster regulatory ...
NEW YORK (AP) — Keryx Biopharmaceuticals Inc. and AEterna Zentaris Inc. said Wednesday the Food and Drug Administration granted the potential cancer treatment Perifosine ...
Significant Differences Among Candidates' Drug Policies
The differences among the two presidential candidates are sharp, including that of drug policies. According to The News-Sentinel October 20, 2008 article, ("McCain Would Focus On ...
Promising Clinical Data with RegeneRx's Tβ4 Drug Candidates ...
Oct 2, 2009 - REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex RGN) (www.regenerx.com) today reported on several clinical studies with Thymosin beta 4 (T 4) present
